Testing effectiveness (Phase 2)Study completedNCT04780321
What this trial is testing
JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects
Who this might be right for
COVID-19
Shanghai Junshi Bioscience Co., Ltd. 62